Major pharmaceutical identified need to ensure commercial and investment priorities align with strategic direction of senior government healthcare policies (not simply with advice emerging from within related ministries).
Devised strategy to discover and engage related experts and interest groups across different stakeholders. Cultivated perspectives from relevant thought leaders. Identified and responded to related senior policymaker priorities with on‐going institutional engagement and increased visibility into critical relationships.
Constructed influence map and engaged with senior policymaker contacts and advisors.
Company successfully adjusted commercial and investment priorities. Senior government official recommended ongoing training program with important government agency as mechanism for continued engagement.